T75

TAK-715

Created:	2011-06-28
Last modified:	2020-06-05

Find Related PDB Entry
2 entries where T75 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	50
Chiral Atom Count	0
Bond Count	53
Aromatic Bond Count	23

2D diagram of T75

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	TAK-715
Synonyms	N-{4-[2-ETHYL-4-(3-METHYLPHENYL)-1,3-THIAZOL-5-YL]PYRIDIN-2-YL}BENZAMIDE
Systematic Name (OpenEye OEToolkits)	N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]pyridin-2-yl]benzamide
Formula	C₂₄ H₂₁ N₃ O S
Molecular Weight	399.508
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(c1ccccc1)Nc4nccc(c3sc(nc3c2cc(ccc2)C)CC)c4
SMILES	CACTVS	3.385	CCc1sc(c2ccnc(NC(=O)c3ccccc3)c2)c(n1)c4cccc(C)c4
SMILES	OpenEye OEToolkits	1.9.2	CCc1nc(c(s1)c2ccnc(c2)NC(=O)c3ccccc3)c4cccc(c4)C
Canonical SMILES	CACTVS	3.385	CCc1sc(c2ccnc(NC(=O)c3ccccc3)c2)c(n1)c4cccc(C)c4
Canonical SMILES	OpenEye OEToolkits	1.9.2	CCc1nc(c(s1)c2ccnc(c2)NC(=O)c3ccccc3)c4cccc(c4)C
InChI	InChI	1.03	InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28)
InChIKey	InChI	1.03	HEKAIDKUDLCBRU-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB16108
Name	TAK-715
Groups	investigational
Description	TAK-715 is under investigation in clinical trial NCT00760864 (Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis).
Synonyms	TAK-715
Categories	Acids, Carbocyclic Amides Benzene Derivatives Benzoates Sulfur Compounds Tumor Necrosis Factor Blockers
CAS number	303162-79-0

Related Resource References

Resource Name	Reference
Pharos	CHEMBL363648
PubChem	9952773
ChEMBL	CHEMBL363648
ChEBI	CHEBI:91360

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.